TWAV Nasdaq Services-Computer Programming, Data Processing, Etc. Financials FY2016βFY2025
TaoWeave, Inc. had $2.4M of revenue in fiscal 2025, up 2.5% on the year before. Over five years, revenue changed β30.8% a year on average.
Last close Β· Oct 23, 2026
$1.44
0.7%Hi! I read TaoWeave, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+2.5%
Only a little. Sales grew 2.5% last year.
Does it make a profit?
β260.8%
No. It lost money last year.
How healthy are the accounts?
3 / 7
Weak. It passes 3 of 7 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days TaoWeave, Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
November 12, 2026
Thursday Β· in 17 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Aug 7, 2026 | Q2 '26 | After the market closes | 10-Q β |
| May 15, 2026 | Q1 '26 | After the market closes | 10-Q β |
| Mar 20, 2026 | Q4 '25 | After the market closes | 10-K β |
| Nov 13, 2025 | Q3 '25 | Before the market opens | 8-K β |
| Aug 14, 2025 | Q2 '25 | Before the market opens | 8-K β |
| May 13, 2025 | Q1 '25 | Before the market opens | 8-K β |
| Mar 18, 2025 | Q4 '24 | After the market closes | 8-K β |
| Nov 7, 2024 | Q3 '24 | Before the market opens | 8-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· TaoWeave, Inc. had $2.4M of revenue in fiscal 2025, up 2.5% on the year before. Over five years, revenue changed β30.8% a year on average. Its operating margin was β121.5%, up 55.2Β pts: of every 100 in sales, about β122 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· TaoWeave, Inc. lost $6.4M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably TaoWeave, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $9.0M | $3.1M | $6.5M | $5.0M | $2.3M |
| Debt incl. finance leases | $0.0M | β | β | β | β |
| Debt / equity | 0.0x | β | β | β | β |
| Current ratio | 5.1x | 2.5x | 4.9x | 4.1x | 6.9x |
| Quick ratio | 4.4x | 2.2x | 4.8x | 4.1x | 6.9x |
| Total assets | $28.6M | $5.7M | $6.9M | $5.3M | $8.2M |
| Total liabilities | $3.1M | $2.0M | $1.4M | $1.3M | $1.2M |
| Shareholders' equity | $25.5M | $3.6M | $5.5M | $4.0M | $7.0M |
| Net debt (β = net cash) | β$9.0M | β | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· TaoWeave, Inc. passes 3 of 7 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 7 | 4 / 8 | 4 / 9 | 5 / 9 | 4 / 9 | 2 / 8 | 3 / 8 | 1 / 7 | 3 / 7 |
| Accruals ratio | β22.5% | 26.2% | β51.4% | β21.0% | β2.7% | β4.6% | β93.4% | β22.1% | β10.4% | β49.5% |
| Altman Z'' | β38.77 | β31.68 | β69.80 | β16.72 | β19.63 | β14.82 | β149.72 | β102.54 | β140.63 | β85.24 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | β | $14.8M | $12.6M | $12.8M | $15.3M | $7.7M | $5.5M | $3.8M | $2.4M | $2.4M |
| Gross profit | β | β | $5.0M | $5.4M | $8.1M | $2.7M | $1.5M | $0.9M | $0.3M | $1.0M |
| Research and development | β | $1.1M | $0.9M | $2.0M | $3.7M | $2.9M | $1.7M | $0.0M | $0.2M | $0.0M |
| Operating income | β$2.1M | β$2.4M | β$6.7M | β$7.6M | β$10.1M | β$11.8M | β$22.0M | β$4.5M | β$4.2M | β$3.0M |
| Interest expense | $1.5M | $1.0M | $0.3M | β | β | β | β | β | β | β |
| Pretax income | β | $5.6M | β$7.2M | β$7.8M | β$7.3M | β$9.1M | β$21.9M | β$4.4M | β$4.0M | β$6.4M |
| Income tax | β$0.1M | β$0.2M | $0.0M | $0.0M | $0.1M | β$0.1M | β$0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$3.5M | $5.8M | β$7.2M | β$7.8M | β$7.4M | β$9.1M | β$21.9M | β$4.4M | β$4.0M | β$6.4M |
| Net income to common | β$3.5M | $5.7M | β$7.2M | β$7.8M | β$8.2M | β$9.8M | β$21.9M | β$5.5M | β$13.1M | β$6.4M |
| Diluted EPS | β$0.10 | $0.14 | β$0.15 | β$1.52 | β$1.48 | β$5.48 | β$10.62 | β$0.98 | β | β |
| Diluted shares | 0.04B | 0.04B | 0.05B | 0.01B | 0.01B | 0.00B | 0.00B | 0.01B | β | β |
| Cash flow | ||||||||||
| Cash from operations | $0.2M | $1.6M | β$1.2M | β$3.3M | β$6.6M | β$7.7M | β$5.9M | β$3.0M | β$3.4M | β$3.0M |
| Capital expenditure | $0.4M | $0.1M | $0.3M | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M | β | β |
| Free cash flow | β$0.2M | $1.5M | β$1.5M | β$3.3M | β$6.6M | β$7.8M | β$5.9M | β$3.0M | β | β |
| Depreciation and amortization | $2.0M | $1.6M | $0.8M | $1.3M | $3.1M | $2.7M | $1.9M | $0.3M | $0.0M | β |
| Stock-based compensation | $0.9M | $0.5M | $0.4M | $0.1M | $0.2M | $0.6M | $0.1M | $0.5M | $0.1M | $0.2M |
| Share buybacks | $0.0M | $2.3M | $0.1M | $0.1M | $0.0M | β | β | β | β | β |
| Dividends and buybacks | $0.0M | $2.3M | $0.1M | $0.1M | $0.0M | β | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.1M | $3.9M | $2.0M | $4.6M | $5.3M | $9.0M | $3.1M | $6.5M | $5.0M | $2.3M |
| Total debt | $10.7M | $1.6M | $0.0M | $5.5M | $2.4M | $0.0M | β | β | β | β |
| Current assets | $3.8M | $5.9M | $3.9M | $9.9M | $10.0M | $12.8M | $4.9M | $6.9M | $5.3M | $8.2M |
| Current liabilities | $12.3M | $2.8M | $1.1M | $8.3M | $5.6M | $2.5M | $1.9M | $1.4M | $1.3M | $1.2M |
| Inventory | β | β | $0.0M | $1.8M | $0.9M | $1.8M | $0.7M | $0.2M | $0.0M | $0.0M |
| Property and equipment, net | $2.2M | $1.2M | $0.7M | $1.3M | $0.6M | $0.2M | $0.0M | $0.0M | $0.0M | β |
| Goodwill | $9.2M | $7.8M | $2.8M | $7.9M | $7.4M | $7.4M | $0.0M | $0.0M | $0.0M | β |
| Intangible assets | $1.3M | $0.6M | $0.5M | $12.6M | $10.1M | $7.6M | $0.6M | $0.0M | $0.0M | $0.0M |
| Total assets | $16.5M | $15.4M | $8.0M | $34.9M | $29.1M | $28.6M | $5.7M | $6.9M | $5.3M | $8.2M |
| Total liabilities | $12.6M | $3.2M | $1.1M | $13.1M | $7.1M | $3.1M | $2.0M | $1.4M | $1.3M | $1.2M |
| Preferred stock | β | β | β | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $3.9M | $12.3M | $6.8M | $21.8M | $22.1M | $25.5M | $3.6M | $5.5M | $4.0M | $7.0M |
| Margins | ||||||||||
| Gross margin | β | β | 39.5% | 42.1% | 52.5% | 35.1% | 28.2% | 23.9% | 13.9% | 41.6% |
| Operating margin | β | β16.0% | β53.7% | β59.0% | β65.6% | β152.4% | β401.5% | β118.0% | β176.7% | β121.5% |
| EBITDA margin | β | β5.0% | β47.7% | β48.7% | β45.2% | β117.0% | β366.8% | β108.9% | β176.7% | β |
| Net margin | β | 39.1% | β57.1% | β60.5% | β48.4% | β117.0% | β400.7% | β115.1% | β170.0% | β260.8% |
| FCF margin | β | 10.0% | β11.9% | β25.7% | β43.1% | β100.6% | β108.6% | β78.6% | β | β |
| Returns | ||||||||||
| Return on capital | β12.2% | β24.0% | β110.4% | β26.4% | β41.4% | β56.5% | β | β | β | β |
| Return on capital employed | β50.1% | β18.7% | β98.7% | β28.4% | β42.7% | β45.2% | β586.7% | β81.3% | β105.0% | β42.1% |
| Return on equity | β89.9% | 71.5% | β75.1% | β54.2% | β33.9% | β38.1% | β150.7% | β96.2% | β85.1% | β115.2% |
| Return on assets | β21.4% | 36.2% | β61.3% | β36.2% | β23.2% | β31.3% | β128.1% | β69.7% | β66.3% | β94.2% |
| Return on tangible equity | β | 147.1% | β203.1% | β596.8% | β180.8% | β92.3% | β728.0% | β100.0% | β327.4% | β90.8% |
| Growth | ||||||||||
| Revenue growth | β | β | β15.1% | 2.2% | 19.5% | β49.5% | β29.2% | β30.4% | β37.6% | 2.5% |
| Net income growth | β | β | β223.9% | β | β | β | β | β | β | β |
| EPS growth | β | β | β207.1% | β | β | β | β | β | β | β |
| FCF growth | β | β | β200.9% | β | β | β | β | β | β | β |
| Share count change | β | 16.4% | 15.7% | β89.3% | 8.6% | β67.9% | 16.1% | 170.9% | β | β |
| Financial health | ||||||||||
| Debt / equity | 2.7x | 0.1x | 0.0x | 0.3x | 0.1x | 0.0x | β | β | β | β |
| Interest coverage | β1.4x | β2.3x | β21.7x | β | β | β | β | β | β | β |
| Current ratio | 0.3x | 2.1x | 3.5x | 1.2x | 1.8x | 5.1x | 2.5x | 4.9x | 4.1x | 6.9x |
| Quick ratio | 0.3x | 2.1x | 3.5x | 1.0x | 1.6x | 4.4x | 2.2x | 4.8x | 4.1x | 6.9x |
| Capital allocation | ||||||||||
| Capex / revenue | β | 0.9% | 2.7% | 0.4% | 0.2% | 0.6% | 0.2% | 0.0% | β | β |
| Stock comp / revenue | β | 3.1% | 2.9% | 0.9% | 1.3% | 7.7% | 2.7% | 13.2% | 2.6% | 6.9% |
| Payouts / FCF | β | 157.5% | β | β | β | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 4.0 | 4.0 | 5.0 | 4.0 | 2.0 | 3.0 | 1.0 | 3.0 |
| Altman Z'' | β38.8 | β31.7 | β69.8 | β16.7 | β19.6 | β14.8 | β149.7 | β102.5 | β140.6 | β85.2 |
| Accruals ratio | β22.5% | 26.2% | β51.4% | β21.0% | β2.7% | β4.6% | β93.4% | β22.1% | β10.4% | β49.5% |
Source: SEC EDGAR XBRL filings (CIK 0000746210). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
